American CryoStem Announces ACS Laboratories Adipose Tissue and Adult Stem Cell Testing Services
April 30 2012 - 9:00AM
Marketwired
American CryoStem Corporation (OTCQB: CRYO) announced the launch of
its new adipose tissue and adult stem cell testing services to
assist physicians involved in tissue engraftment, regenerative
medicine procedures and cellular therapies utilizing adult adipose
derived stem cells. The new testing services provide physicians an
affordable method for self assessment of their procedures and
methods to better understand the relationship between tissue
quality and engraftment success.
American CryoStem recognizes the need for independent testing
services as reinforced by the increasing focus and scrutiny of
physician office based tissue laboratories by the US Food and Drug
Administration (FDA). The menu of testing services includes full 14
day sterility testing, viability testing, growth assay and
additional tests for each selected service. The tests can be
ordered individually or in multiples over time and are designed to
allow physicians to self evaluate their current methods and
performance, or to assess new methods or devices designed to
improve procedure and tissue quality. Long term and customized
programs are available upon request. Physicians enrolled as a
provider of the Company's stem cell storage services can obtain
discounts for individual and multi test programs.
"We are very excited about rolling these new services out to our
existing providers and all participants in the tissue engraftment,
regenerative medicine and cellular therapy markets. We believe that
this is the first such program offered commercially and meets a
critical need for the advancement of the regenerative and cellular
therapy markets," said Anthony Dudzinski, the Company's COO. "Now
there is a way for physicians to assess their own performance
without the need to overcome the significant costs of purchasing
and maintaining their own testing facilities."
The new testing services are offered by ACS Laboratories
reflects the Company's increasing branding and commercialization of
products and services developed around its proprietary clinical
tissue processing and storage methodologies. ACS Laboratory
incorporates its proprietary cGMP/cGTP aseptic methods and FDA
guidance's into these services to ensure the highest quality and
most useful information for physicians.
About American CryoStem: American CryoStem
Corporation (OTCQB: CRYO) markets clinical processing services and
patented products for Adipose (fat) Tissue and Adipose Derived
Adult Stem Cells. The Company's clinical processing, patented cell
culture media products and cellular preservation platform supports
the science and regenerative medicine applications being developed
globally. The Company provides the highest quality, clinically
processed cells assuring their purity, viability and growth
capabilities, while at the same time developing cutting edge
applications, therapies and patented laboratory products and
services for consumer and commercial applications.
Add to Digg Bookmark with del.icio.us Add to Newsvine
For More Information, contact: Investor Relations
American CryoStem Corporation 188 East Bergen Place, Suite 204 Red
Bank, NJ 07701 Phone:732-747-1007 www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024